Made With Uberflip Content Marketing

Biotech startups

Find out the latest in biopharma innovation here as we explore opportunities for investing in early stage biotech startups.

  • Barcelona biotech companies shine light on regional entrepreneurship

    Barcelona biotech companies shine light on regional entrepreneurship

    Investors are always on the lookout for innovative biotech startups, and the Catalonia, Spain biopharma cluster has plenty to offer in the way of innovation from among its member companies....

    Read
  • Why the connected patient is the killer app in the digital age of medicine

    Why the connected patient is the killer app in the digital age of medicine

    Guest article by Deb Kilpatrick, PhD, CEO at Evidation Health and Rich Milani, MD, FACC, FAHA, Chief Clinical Transformation Officer at Ochsner Health System If you search on the phrase “killer...

    Read
  • Barcelona’s GP Pharm considers partnering key to international expansion

    Barcelona’s GP Pharm considers partnering key to international expansion

    Barcelona is an attractive location for business and trade, and has experienced a revival in the biopharma sector in recent years with the outsourcing of innovation from pharma companies to...

    Read
  • Who gets funded? Imaginative companies!

    Who gets funded? Imaginative companies!

    The biotech industry needs a new approach that approximates the type of disruption that Uber brought to transportation and Amazon and eBay brought to retail sales. Instead of embracing those lean...

    Read
  • UK Establishment upbeat about Brexit’s effect on British life science industry

    UK Establishment upbeat about Brexit’s effect on British life science industry

    Brexit may no longer be at the top of popular news, but it continues to be a key concern for biopharma companies in post-Brexit 2017. The sentiment of key players from the UK life sciences from a...

    Read
  • It’s all happening at Biotech Showcase™ Week

    It’s all happening at Biotech Showcase™ Week

    Guest post by Constantine Theodoropulos, President, GO Therapeutics Thankfully there is a holiday between now and Biotech Showcase™ Week in San Francisco (Jan 9–11), because we are going to need...

    Read
  • Inositec CEO on 2017 financing plans

    Inositec CEO on 2017 financing plans

    Inositec is developing innovative new drugs using its proprietary Inositune technology to adjust the properties of inositol phosphate analogs, says CEO Mattias Ivarsson. Read more » Related...

    Read
  • Digital Health Security: The Most Important Tradeoff Between Ease and Privacy

    Digital Health Security: The Most Important Tradeoff Between Ease and Privacy

    Guest post by Nicole Fisher, Founder & CEO at HHR Strategies, Inc., Forbes Contributor Wayne Gretzky always said it’s better to look where the puck is going, not where it is now. The introduction...

    Read
  • Thirteen young people bucking the odds, finding paths to break into biotech

    Thirteen young people bucking the odds, finding paths to break into biotech

    Guest post by Luke Timmerman, founder and editor of the Timmerman Report, and a regular contributor to Forbes and STAT News. Walking around San Francisco’s Union Square during biotech conference...

    Read
  • Digital Health: Smart Devices Were Just The Beginning

    Digital Health: Smart Devices Were Just The Beginning

    The connectivity that will be created by the convergence of computers and health will truly alter the way knowledge, technology and insights into the future revolutionize health care.

    Read
  • Cinfa outlines biosimilar development areas and deal opportunities

    Cinfa outlines biosimilar development areas and deal opportunities

    Cinfa Biotech's managing director, Ruediger Jankowsky, discusses the company's founding and focus on biosimilar drug development. Read more » Related Posts Sixth Element Capital outlines...

    Read
  • Biotechs scramble as public markets dry up, but can private equity help?

    Biotechs scramble as public markets dry up, but can private equity help?

    Does the slump in the IPO boom create a bigger pool of private capital to invest in drug development, or do emerging companies have their backs to the wall? Professional investors hold mixed...

    Read
  • A snapshot of hot biotech in Latin America

    A snapshot of hot biotech in Latin America

    According to a report from Deloitte, healthcare spending in Latin America is projected to increase 4.6 percent on average annually between 2014 and 2018, as pharmaceutical spending grows an...

    Read
  • Denmark-based biotech Curasight making strides in cancer therapies

    Denmark-based biotech Curasight making strides in cancer therapies

    CSO and Co-Founder of Curasight Andreas Kjaer describes his company's efforts to develop novel, innovative radionuclide therapies for cancer, while raising its profile outside of Denmark. Read...

    Read
  • Qualcomm Life brings players in the healthcare ecosystem toward digital transformation

    Qualcomm Life brings players in the healthcare ecosystem toward digital transformation

    Disruption to the healthcare ecosystem means disruption to a USD 4 trillion industry. This is no small feat. Luckily, companies like Qualcomm are up to the task, as outlined by Dr. James Mault of...

    Read
  • BioPharm America™ 2016: What makes a serial entrepreneur so successful and what makes them tick?1:03:16

    BioPharm America™ 2016: What makes a serial entrepreneur so successful and what makes them tick?

    Who are the top serial entrepreneurs in biotech? What kind of person does it take to enter a company at the beginning, or at a nascent stage of high ambiguity, and find a way to create value? Hear mor

    Watch Video
  • BioPharm America™ 2016: Has the IPO window closed?48:48

    BioPharm America™ 2016: Has the IPO window closed?

    After outperforming the rest of the field for three straight years, the end of Q2 showed a decided chill in the market toward recent biotech IPOs. Has the window of opportunity closed? If so, what are

    Watch Video
  • Protecting your IP: Checklist

    Protecting your IP: Checklist

    In biotechnology you cannot get very far without solid IP. For a startup company, having a solid IP strategy is an essential requirement to maximizing value. Muna Abu-Shaar, PhD, Founder of...

    Read
  • Top tips from investors on pitching your company from BioPharm America™ 2016

    Top tips from investors on pitching your company from BioPharm America™ 2016

    A group of seasoned biotech investors gathered this week at BioPharm America™ to meet with innovative biotech companies, and to participate in “The Perfect Pitch: Do you have what it takes to win...

    Read
  • Companies to Watch: Biotech IPOs, where do we go from here?

    Companies to Watch: Biotech IPOs, where do we go from here?

    One constant thread that runs through most biotech financing conversations these days centers on the biotech IPO market. After a tsunami of biotech offerings crashed into Wall Street from early...

    Read
  • loading
    Loading More...